1. Кравец Е.Б., Саприна Т.В., Лазаренко Ф.Э. и др. Роль цитокинов в патогенезе аутоиммунного диабета, вопросы иммуноинтервенции//Бюл. сиб. медицины. 2010. Т. 9, № 1. С. 76-83.
2. Кричевская О.А., Клюквина Н.Г., Александрова Е.Н. и др. Фактор некроза опухоли α и его растворимые рецепторы при ревматических заболеваниях: клиническое и патогенетическое значение//Науч.-практ. ревматология. 2005. № 2. С. 43-46.
3. Саприна Т.В., Лазаренко Ф.Э., Прохоренко Т.С. и др. Особенности базальной и стимулированной секреции интерлейкинов-2 и -4 мононуклеарами крови при аутоиммунном диабете//Сиб. мед. журн. 2010. Т. 25, № 1. С. 41-44.
4. Смирнова О.М., Кононенко И.В., Дедов И.И. Аутоиммунный латентный сахарный диабет у взрослых//Проблемы эндокринологии. 2008. Т. 54, № 2. С. 1-7.
5. Atkinson M.A., Gianani R. The pancreas in human type 1 diabetes: providing new answers to age-old questions//Curr. Opin. Endocrinol. Diabetes Obes. 2009. V. 16, № 4. P. 279-285.
6. Ban L., Zhang J., Wang L. Selective death of autoreactive T cells in human diabetes by TNF or TNF receptor 2 agonism//The National Acad. of Scien. 2008. V. 105, № 36. P. 13644-13649.
7. Ben-Mahmud B.M., Chan W.H., Abdulahad R.M. et al. Clinical validation of a link between TNF-alpha and the glycosylation enzyme core 2 GlcNAc-T and the relationship of this link to diabetic retinopathy//Diabetologia. 2006. V. 49, № 9. P. 2185-2191.
8. Ben-Mahmud B.M., Mann G.E., Datti A. et al. Tumor necrosis factor-alpha in diabetic plasma increases the activity of core 2 GlcNAc-T and adherence of human leukocytes to retinal endothelial sells: significance of core 2 GlcNAc-T in diabetic retinopathy//Diabetes. 2004. V. 53, № 11. P. 2968-2976.
9. Bruun C., Heding P.E., Ronn S.G. et al. Inhibitory effects of suppressor of cytokine signalling-3 on tumor necrosis factor-alpha induced signalling in pancreatic beta cells//Diabetologia. 2005. V. 48. P. 181-188.
10. Bruun C., Heding P.E., Ronn S.G http://www.ncbi.nlm.nih.gov/pubmed?term="Rønn SG"[Author] . Suppressor of cytokine signalling-3 inhibits Tumor necrosis factor-alpha induced apoptosis and signalling in beta cells // Mol. Cell. Endocrinol. 2009. № 13. P. 32-38.
11. Chan F.K. The pre-ligand binding assemble domain: a potential target of inhibition of tumour necrosis factor receptor function//Ann. Rheun. Dis. 2000. V. 59. P. 150-153.
12. Doganay S., Evereklioglu C., Er H. et al. Comrarison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patiens with diabetes mellitus//Eye. 2002. V. 16, № 2. P. 163-170.
13. Fourlanos S., Perry C., Stein M.S. et al. A clinical screening tool identifies autoimmune diabetes in adults//Diabetes Care. 2006. V. 29, № 5. P. 970-975.
14. Hohmeier H.E., Tran W., Chen G. et al. Inflammatory mechanisms in diabetes: lessons from the β-cell//Int. J. Obesity. 2003. V. 27. P. 12-16.
15. Hussain M.J., Maher J., Warnock T. et al. Cytokine overproduction in healthy first degree relatives of patients with IDDM//Diabetologia. 1998. V. 41, N 3. P. 343-349.
16. Hussain M.J., Peakman M., Gallati H. et al. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM//Diabetologia. 1996. V. 39, № 1. P. 60-69.
17. Ihnatko R., Kubes M. TNF signaling: early events and phosphorylation//Gen. Physiol. Biophys. 2007. V. 26, № 3. P. 159-167.
18. Locksley R.M., Killeen N., Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology//Cell. 2001. V. 104. P. 487-501.
19. MacEwan D.J. TNF ligand and receptors -a matter of life and death//British Jour. Of Pharm. 2002. V. 135. P. 855-875.
20. Maioli M., Puddu L., Pes G. M. et al. Latent autoimmune diabetes in adults (Article in Italian)//Clin. Ter. 2006. V. 157, № 1. P. 69-78
21. Margolles-Clark E., Kenyon N.S., Ricordi C. et al. Effective and Specific Inhibition of the CD40-CD154 Costimulatory Interaction by a Naphthalenesulphonic Acid Derivative//Chem. Biol. Drug. Des. 2010. V. 52, № 3. P. 372-386.
22. Ortis F., Pirot P., Naamane N. et al. Induction of nuclear factor-kappaB and its downstream genes by TNF-alpha and IL-1beta has a pro-apoptotic role in pancreatic beta cells//Diabetologia. 2008. V. 51, № 7. P. 1213-1225.
23. Ortis F., Naamane N., Flamez D. et al. Cytokines interleukin-1beta and tumor necrosis factor-alpha regulate different transcriptional and alternative splicing networks in primary beta-cells//Diabetes. 2010. V. 59, № 2. P. 358-374.
24. Rabinovitch A., Suarez-Pinzon W.L. Roles of cytokines in the pathogenesis and therapy of type 1 diabetes//Cell Biochem Biophys. 2007. V. 482, № 3. P. 159-163.
25. Schneider-Brachert W., Tchikov V., Neumeyer J. et al. Compartmentalization of TNF receptor 1 signaling; internalized TNF receptosomes as death vesicles//J. Immunity. 2004. V. 21, № 3. P. 415-428.
26. Schütze S., Tchikov V., Schneider-Brachert W. Regulation of TNFR1 and CD95 signalling by receptor compartmentalization//Nat. Rev. Mol. Cell. Biol. 2008. V. 9, № 8. P. 655-662.
27. Suarez-Pinzon W., Sorensen O., Bleackley R.C. et al. Beta-cell clestruction in NOD mice correlate with Fas (CD 95) expression on beta-cell and proinflammation cytokine expression in islets//Diabetologia. 1999. V. 48, № 1. P. 21-28.
28. Uno S., Imagawa A., Okita K. et al. Macrophages and dendritic cells infiltrating islets with or without beta cells produce tumour necrosis factor-alpha in patients with recen-tonset type 1 diabetes//Diabetologia. 2007. V. 50, № 3. P. 596-601.
29. Wajant H., Pfizenmaier K., Scheurich P. Tumor necrosis factor signaling//Cell. Death. Differ. 2003. V. 10. P. 45-65.
Послать статью по эл. почте 